Skip to content
  • Contact Us
  • Request Samples
  • Order
Mill Creek Life Sciences
  • Our Technology
    • Human Platelet Lysate
    • Applications
    • Dendritic Cell Vaccine
  • Products
    • PLTMax®
    • PLTGold®
    • Order
    • Request Samples
  • Support
    • Technical Support
    • Publications
    • Posters
    • Distributors
    • FAQs
    • Contact Us
  • About Us
    • Our Company
    • Quality
    • News
    • Collaborate
    • Careers
Filters (4)
Filters
  • Reset all ×
  • Fistulas ×

4 resources found

    N/A
Show (4)
Cancel

Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn’s Fistulas (Apr 2020)

Early Results of a Phase I Trial Using an Adipose-Derived Mesenchymal Stem Cell-Coated Fistula Plug for the Treatment of Transsphincteric Cryptoglandular Fistulas (May 2019)

Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn’s Disease (Jul 2017)

Closure of a Recurrent Bronchopleural Fistula Using a Matrix Seeded With Patient-Derived Mesenchymal Stem Cells (Oct 2016)

MillCreekLifeSciences_StackedWhite-01

221 1st Avenue SW, Suite 209 Rochester, Minnesota 55902, USA

Phone: 507-287-6257
Fax: 507-289-2066
Email: info@millcreekls.com

OUR TECHNOLOGY

Human Platelet Lysate

Applications

Dendritic Cell Vaccine

PRODUCTS

PLTMax®

PLTGold®

Order

Request Samples

SUPPORT

Technical Support

Publications

Posters

Distributors

FAQs

Contact Us

ABOUT US

Our Company

Quality

News

Collaborate

Careers